These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14092539)

  • 1. [DRUGS INHIBITING ALDOSTERONE SECRETION AND ALDOSTERONE ANTAGONISTS].
    TORIGAI T; FUKUCHI S; HANADA M; TAKAHASHI H; IDEMURA H; KUMAGAI T
    Sogo Rinsho; 1963 Oct; 12():1924-32. PubMed ID: 14092539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of the combination of saluretics and aldosterone inhibitors (SC 9420 and SU 4885) in the treatment of refractory edema].
    VEYRAT R; ENGEL E; DUCOMMUN P; MULLER AF
    Helv Med Acta; 1960 Dec; 27():683-9. PubMed ID: 13781090
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1167-73. PubMed ID: 14152375
    [No Abstract]   [Full Text] [Related]  

  • 4. [EFFECTS OF HYDROCHLOROTHIAZIDE ASSOCIATED WITH ALDOSTERONE ANTAGONISTS IN THE THERAPY OF INFANTILE NEPHROTIC EDEMA. II. STUDY OF OSMOLAR CLEARANCES AND FREE WATER].
    ANIBALDI A; BOSCHERINI B; PAIELLA R
    Prog Med (Napoli); 1963 Sep; 19():548-52. PubMed ID: 14122942
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1124-7. PubMed ID: 14152369
    [No Abstract]   [Full Text] [Related]  

  • 6. [NATRIURETIC DRUGS].
    ARMASCRUZ R; GOMEZ R; MARDONES J; PLAZADELOSREYES M
    Rev Med Chil; 1963 Nov; 91():793-810. PubMed ID: 14125670
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of heparinoid and spirolactone on the renal excretion of sodium and aldosterone.
    CEJKA V; de VRIES L; van DAATSELAAR J; BORST JG; MAJOOR CL
    Lancet; 1960 Feb; 1(7119):317-9. PubMed ID: 13808736
    [No Abstract]   [Full Text] [Related]  

  • 8. [CONTRIBUTION TO THE PROBLEM OF IDIOPATHIC EDEMA].
    BOEHM P; FRANKEN FH; IRMSCHER K
    Klin Wochenschr; 1963 Dec; 41():1155-61. PubMed ID: 14114041
    [No Abstract]   [Full Text] [Related]  

  • 9. THE MANAGEMENT OF ASCITES.
    SMITH AN; MCMANUS J
    Rev Surg; 1964; 21():1-16. PubMed ID: 14106700
    [No Abstract]   [Full Text] [Related]  

  • 10. THE USE OF METYRAPONE AS AN ALDOSTERONE ANTAGONIST.
    DAVIES MS; HETZEL BS; KEARNEY GM; WILSON GM
    Clin Pharmacol Ther; 1964; 5():296-300. PubMed ID: 14168518
    [No Abstract]   [Full Text] [Related]  

  • 11. [TREATMENT OF STATES OF HYPERALDOSTERONISM. THERAPEUTIC INDICATIONS OF SPIRONOLACTONE].
    GUILLEMAN P
    Rev Prat; 1963 Sep; 13():2962-75. PubMed ID: 14091690
    [No Abstract]   [Full Text] [Related]  

  • 12. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
    HOFFMEISTER W
    Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE COMBINATION OF SPIRONOLACTONE AND METOPIRONE IN THE TREATMENT OF DECOMPENSATED LIVER CIRRHOSIS].
    BRUNNER E; RISSEL E
    Wien Klin Wochenschr; 1964 Dec; 76():890-3. PubMed ID: 14336956
    [No Abstract]   [Full Text] [Related]  

  • 14. [METOPIRON-METYRAPONE].
    BINDER C
    Nord Med; 1964 Jul; 74():724-7. PubMed ID: 14312788
    [No Abstract]   [Full Text] [Related]  

  • 15. [USE OF AN INHIBITOR OF ALDOSTERONE SYNTHESIS (SU-4885, METOPIRONE) IN SOME REFRACTORY EDEMATOUS STATES].
    CURCIO R; CASSIA B
    Boll Soc Ital Cardiol; 1963; 8():563-74. PubMed ID: 14122383
    [No Abstract]   [Full Text] [Related]  

  • 16. [ON THE SUBJECT OF DIURESIS WITH METOPIRONE (SU-4885)].
    CEREDA UG; FRANZINI P
    Minerva Med; 1964 Jul; 55():2335-8. PubMed ID: 14181820
    [No Abstract]   [Full Text] [Related]  

  • 17. IDIOPATHIC EDEMA ND HYPERALDOSTERONURIA: POSTURAL VENOUS PLASMA POOLING.
    FISHER DA; MORRIS MD
    Pediatrics; 1965 Mar; 35():413-24. PubMed ID: 14258654
    [No Abstract]   [Full Text] [Related]  

  • 18. [MEASUREMENT OF ALDOSTERONE SECRETION DURING THE ADMINISTRATION OF A SEMI-SYNTHETIC ADRENOSTATIC AGENT, HEPARINOID RO I-8307].
    VEYRAT R; MANNING EL; FABRE J; MULLER AF
    Rev Fr Etud Clin Biol; 1963; 8():667-73. PubMed ID: 14082398
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of aldosterone and aldosterone antagonists in patients with hypoaldosteronism caused by heparinoid].
    CEJKA V; de VRIES L; van DAATSELLAR J; BORST JG
    Ned Tijdschr Geneeskd; 1962 Mar; 106():617-20. PubMed ID: 13877617
    [No Abstract]   [Full Text] [Related]  

  • 20. [OUR EXPERIENCE IN THE TREATMENT OF PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS WITH ALDOSTERONE INHIBITORS].
    KNEZEVIC S; HAHN A
    Lijec Vjesn; 1963 Oct; 85():1085-93. PubMed ID: 14097613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.